Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Apr;38(3):651-653.
doi: 10.1177/02676591211065251. Epub 2022 Jan 3.

MitraClip® procedure as bridge to left ventricular assist device: Enable extracorporeal membrane oxygenation weaning and reduce perioperative risk

Martin O Schmiady  1 , Stephan Winnik  2 , Dominique Bettex  3 , Raed Aser  1
Affiliations
Case Reports

MitraClip® procedure as bridge to left ventricular assist device: Enable extracorporeal membrane oxygenation weaning and reduce perioperative risk

Martin O Schmiady et al. Perfusion. 2023 Apr.

Abstract

Secondary mitral valve regurgitation is a frequent consequence of left ventricular dysfunction in patients with severe heart failure. The management of this disease can be challenging since it often culminates in refractory pulmonary edema and multi-organ failure. We present the case of a 50-year-old male who was admitted in cardiogenic shock following myocardial infarction. After successful revascularization, percutaneous mitral valve repair using the MitraClip® device enabled weaning from extracorporeal membrane oxygenation followed by the implantation of a left ventricular assist device as bridge to transplant.

Keywords: Impella® microaxial blood pump; MitraClip®, extracorporeal membrane oxygenation; cardiac shock; left ventricular assist device; mitral regurgitation, end-stage heart failure.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Transesophageal echocardiography of the mitral valve with severe mitral regurgitation due to coaptation defect (0.7 mm) between P3 and A3 (A and B). TEE image and 3D image after clip implantation showing a significant reduction of the regurgitation jet (D and E). Regression of pulmonary edema after MitraClip® implantation, with two clips in place (F), compared to preoperative conditions (C).
See this image and copyright information in PMC

References

    1. Franzen O, Baldus S, Rudolph V, et al. Acute outcomes of mitraclip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 2010; 31(11): 1373–1381. DOI: 10.1093/eurheartj/ehq050. - DOI - PubMed
    1. Berardini A, Biagini E, Saia F, et al. Percutaneous mitral valve repair: the last chance for symptoms improvement in advanced refractory chronic heart failure? Int J Cardiol 2017; 228: 191–197. DOI: 10.1016/j.ijcard.2016.11.241. - DOI - PubMed
    1. Auricchio A, Schillinger W, Meyer S, et al. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by mitraclip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol 2011; 58(21): 2183–2189. DOI: 10.1016/j.jacc.2011.06.061. - DOI - PubMed
    1. Ammirati E, Van De Heyning CM, Musca F, et al. Safety of centrifugal left ventricular assist device in patients previously treated with mitraclip system. Int J Cardiol 2019; 283: 131–133. DOI: 10.1016/j.ijcard.2019.02.039. - DOI - PubMed

Publication types